{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:18:29Z","timestamp":1780341509595,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To investigate the feasibility of recruiting into a pelvic floor muscle training (PFMT) program delivered via telehealth to treat urinary incontinence (UI) in women with breast cancer on aromatase inhibitors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a pre-post single cohort clinical trial with 54 women with breast cancer. Participants underwent a 12-week PFMT program using an intra-vaginal pressure biofeedback device: femfit<jats:sup>\u00ae<\/jats:sup>. The intervention included eight supervised individual PFMT sessions over Zoom<jats:sup>\u2122<\/jats:sup> and a 12-week home exercise program. The primary outcome of this study was feasibility, specifically consent rate. Secondary outcomes which included prevalence and burden of UI measured using the International Consultation on Incontinence Questionnaire\u2013Urinary Incontinence Short Form (ICIQ-UI SF), and pelvic floor muscle (PFM) strength measured as intravaginal squeeze pressure were compared using McNemar\u2019s and paired <jats:italic>t<\/jats:italic> tests.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The mean age of participants was 50\u00a0years (SD\u2009\u00b1\u20097.3). All women who were eligible to participate in this study consented (<jats:italic>n<\/jats:italic>\u2009=\u200955\/55, 100%). All participants reported that the program was beneficial and tailored to their needs. The results showed a statistically significant decline in the prevalence (percentage difference 42%, 95% CI 28, 57%) and burden (ICIQ-UI SF score mean change 9.4, 95% CI 8.5, 10.4) of UI post intervention. A significant increase in PFM strength was observed post-intervention (mean change 4.8\u00a0mmHg, 95% CI 3.9, 5.5).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study indicated that PFMT delivered via telehealth may be feasible and potentially beneficial in treating stress UI in women with breast cancer. Further studies such as randomized controlled trials are required to confirm these results.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12282-022-01405-6","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T16:04:28Z","timestamp":1664208268000},"page":"121-130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The feasibility of pelvic floor training to treat urinary incontinence in women with breast cancer: a telehealth intervention trial"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0662-9363","authenticated-orcid":false,"given":"Udari N.","family":"Colombage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze-Ee","family":"Soh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Yin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Kruger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena C.","family":"Frawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,26]]},"reference":[{"key":"1405_CR1","first-page":"1176","volume-title":"Incontinence","author":"C Dumoulin","year":"2017","unstructured":"Dumoulin C, Adewuyi T, Booth J, Bradley C, Burgio K, Hagen S, Hunter K, Imamura M, Morin M, Morkved S, Thakar R, Wallace S, Williams K. Adult conservative management. In: Abrams P, Cardozo L, Wagg A, Wein A, editors. Incontinence, vol. 2. 6th ed. UK: International Continence Society; 2017. p. 1176\u201380.","edition":"6"},{"issue":"1","key":"1405_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/nau.24531","volume":"40","author":"U Colombage","year":"2021","unstructured":"Colombage U, Lin K-Y, Soh S-E, Frawley H. Prevalence and impact of bladder and bowel disorders in women with breast cancer: a systematic review with meta-analysis. Neurourol Urodyn. 2021;40(1):15\u201327. https:\/\/doi.org\/10.1002\/nau.24531.","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"1405_CR3","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000446941FromEBSCOhostjlh","volume":"11","author":"C Liedtke","year":"2016","unstructured":"Liedtke C, Thill M. AGO recommendations for the diagnosis and treatment of patients with early breast cancer: update 2016. Breast Care. 2016;11(3):204\u201314. https:\/\/doi.org\/10.1159\/000446941FromEBSCOhostjlh.","journal-title":"Breast Care"},{"key":"1405_CR4","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/cncr.26324","volume":"118","author":"KA Donovan","year":"2012","unstructured":"Donovan KA, Boyington AR, Ismail-Khan R, Wyman JF. Urinary symptoms in breast cancer. CA Cancer J Clin. 2012;118:582\u201393. https:\/\/doi.org\/10.1002\/cncr.26324.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1405_CR5","doi-asserted-by":"publisher","first-page":"26.e21","DOI":"10.1016\/j.ajog.2010.08.035","volume":"204","author":"J Baumgart","year":"2011","unstructured":"Baumgart J, Nilsson K, Stavreus-Evers A, Kask K, Villman K, Lindman H, Kallak T, Sundstr\u00f6m-Poromaa I. Urogenital disorders in women with adjuvant endocrine therapy after early breast cancer. Am J Obstet Gynecol. 2011;204(1):26.e21-26.e27. https:\/\/doi.org\/10.1016\/j.ajog.2010.08.035.","journal-title":"Am J Obstet Gynecol"},{"key":"1405_CR6","doi-asserted-by":"publisher","DOI":"10.17784\/mtprehabjournal.2017.15.462","author":"TMA da Concei\u00e7\u00e3o","year":"2017","unstructured":"da Concei\u00e7\u00e3o TMA, Daroza T, Dossantos K, da Luz SCT, da Luz CM. Pelvic floor muscles contraction and sexual function are associated with hormonal treatment in women after breast cancer? Man Ther Posturology Rehabil J. 2017. https:\/\/doi.org\/10.17784\/mtprehabjournal.2017.15.462.","journal-title":"Man Ther Posturology Rehabil J"},{"issue":"10","key":"1405_CR7","doi-asserted-by":"publisher","first-page":"CD005654","DOI":"10.1002\/14651858.CD005654.pub4","volume":"10","author":"C Dumoulin","year":"2018","unstructured":"Dumoulin C, Cacciari LP, Hay-Smith EJC. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. The Cochrane Database Syst Rev. 2018;10(10):CD005654. https:\/\/doi.org\/10.1002\/14651858.CD005654.pub4.","journal-title":"The Cochrane Database Syst Rev"},{"key":"1405_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/1758834016687260","volume":"9","author":"MS Sousa","year":"2017","unstructured":"Sousa MS, Peate M, Jarvis S, Hickey M, Friedlander M. A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy. Ther Adv Med Oncol. 2017;9:269\u201385. https:\/\/doi.org\/10.1177\/1758834016687260.","journal-title":"Ther Adv Med Oncol"},{"key":"1405_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-020-04588-8","author":"KRU da Mata","year":"2020","unstructured":"da Mata KRU, Costa RCM, Carbone \u00c9SM, Gimenez MM, Bortolini MAT, Castro RA, Fitz FF. Telehealth in the rehabilitation of female pelvic floor dysfunction: a systematic literature review. Int Urogynecol J. 2020. https:\/\/doi.org\/10.1007\/s00192-020-04588-8.","journal-title":"Int Urogynecol J"},{"key":"1405_CR10","unstructured":"Report of the WCPT\/INPTRA Digital physical therapy practice task force. World confederation for physiotherapy & international network of physiotherapy regulatory authorities 2019."},{"key":"1405_CR11","first-page":"110","volume-title":"Evidence-based physical therapy for the pelvic floor","author":"K Bo","year":"2015","unstructured":"Bo K, Siv M. Ability to contract the pelvic floor muscles. In: Evidence-based physical therapy for the pelvic floor. Edinburgh: Elsevier; 2015. p. 110\u20137."},{"issue":"1","key":"1405_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/nau.24179","volume":"39","author":"LP Cacciari","year":"2020","unstructured":"Cacciari LP, Kruger J, Goodman J, Budgett D, Dumoulin C. Reliability and validity of intravaginal pressure measurements with a new intravaginal pressure device: the FemFit. Neurourol Urodyn. 2020;39(1):253\u201360. https:\/\/doi.org\/10.1002\/nau.24179.","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"1405_CR13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"A-W Chan","year":"2013","unstructured":"Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200\u20137. https:\/\/doi.org\/10.7326\/0003-4819-158-3-201302050-00583.","journal-title":"Ann Intern Med"},{"key":"1405_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.physio.2021.03.001FromNLM","volume":"112","author":"SC Slade","year":"2021","unstructured":"Slade SC, Morris ME, Frawley H, Hay-Smith J. Comprehensive reporting of pelvic floor muscle training for urinary incontinence: CERT-PFMT. Physiotherapy. 2021;112:103\u201312. https:\/\/doi.org\/10.1016\/j.physio.2021.03.001FromNLM.","journal-title":"Physiotherapy"},{"issue":"10","key":"1405_CR15","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1001\/jamainternmed.2020.2993FromNLM","volume":"180","author":"C Dumoulin","year":"2020","unstructured":"Dumoulin C, Morin M, Danieli C, Cacciari L, Mayrand MH, Tousignant M, Abrahamowicz M. Group-based vs individual pelvic floor muscle training to treat urinary incontinence in older women: a randomized clinical trial. JAMA Intern Med. 2020;180(10):1284\u201393. https:\/\/doi.org\/10.1001\/jamainternmed.2020.2993FromNLM.","journal-title":"JAMA Intern Med"},{"issue":"4","key":"1405_CR16","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/ptj\/pzx006FromNLM","volume":"97","author":"HC Frawley","year":"2017","unstructured":"Frawley HC, Dean SG, Slade SC, Hay-Smith EJC. Is pelvic-floor muscle training a physical therapy or a behavioral therapy? A call to name and report the physical, cognitive, and behavioral elements. Phys Ther. 2017;97(4):425\u201337. https:\/\/doi.org\/10.1093\/ptj\/pzx006FromNLM.","journal-title":"Phys Ther"},{"key":"1405_CR17","unstructured":"Australian Statistical Geography Standard (ASGS): Volume 4 - Significant urban areas, urban centres and localities, section of state (cat. no. 1270.0.55.004). 2017. https:\/\/www.abs.gov.au\/ausstats\/abs@.nsf\/mf\/1270.0.55.004."},{"key":"1405_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i5239","volume":"355","author":"SM Eldridge","year":"2016","unstructured":"Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, Lancaster GA. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ. 2016;355: i5239. https:\/\/doi.org\/10.1136\/bmj.i5239.","journal-title":"BMJ"},{"issue":"3","key":"1405_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150205FromNLM","volume":"11","author":"SM Eldridge","year":"2016","unstructured":"Eldridge SM, Lancaster GA, Campbell MJ, Thabane L, Hopewell S, Coleman CL, Bond CM. Defining feasibility and pilot studies in preparation for randomised controlled trials: development of a conceptual framework. PLoS ONE. 2016;11(3): e0150205. https:\/\/doi.org\/10.1371\/journal.pone.0150205FromNLM.","journal-title":"PLoS ONE"},{"key":"1405_CR20","unstructured":"NIHR. Guidance on applying for feasibility studies. 2021. https:\/\/www.nihr.ac.uk\/documents\/nihr-research-for-patient-benefit-rfpb-programme-guidance-on-applying-for-feasibility-studies\/20474. Accessed 9 Aug 2022."},{"issue":"11","key":"1405_CR21","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1007\/s00192-020-04576-y","volume":"32","author":"J Marriott","year":"2021","unstructured":"Marriott J, Pedofsky L, Smalldridge J, Hayward L, Budgett D, Nielsen PMF, Kruger J. Assessing vaginal pressure profiles before and after prolapse surgery using an intravaginal pressure sensor (femfit\u00ae). Int Urogynecol J. 2021;32(11):3037\u201344. https:\/\/doi.org\/10.1007\/s00192-020-04576-y.","journal-title":"Int Urogynecol J"},{"issue":"1","key":"1405_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/nau.24179FromNLM","volume":"39","author":"LP Cacciari","year":"2020","unstructured":"Cacciari LP, Kruger J, Goodman J, Budgett D, Dumoulin C. Reliability and validity of intravaginal pressure measurements with a new intravaginal pressure device: the femfit\u00ae. Neurourol Urodyn. 2020;39(1):253\u201360. https:\/\/doi.org\/10.1002\/nau.24179FromNLM.","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"1405_CR23","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/nau.20041","volume":"23","author":"K Avery","year":"2004","unstructured":"Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P. ICIQ: A brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004;23(4):322\u201330. https:\/\/doi.org\/10.1002\/nau.20041.","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"1405_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jmpt.2003.11.003","volume":"27","author":"H Hurst","year":"2004","unstructured":"Hurst H, Bolton J. Assessing the clinical significance of change scores recorded on subjective outcome measures. J Manipulative Physiol Ther. 2004;27(1):26\u201335. https:\/\/doi.org\/10.1016\/j.jmpt.2003.11.003.","journal-title":"J Manipulative Physiol Ther"},{"key":"1405_CR25","unstructured":"Coyne K, Sikirica V, Gelhorn H, Robinson D, Hinoul P, Gauld J. Validation of the patient global impression of change (PGIC) in a patient population following vaginal prolapse repair with mesh. Medicine 2010, Abstract."},{"issue":"4S","key":"1405_CR26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0022-5347(08)60321-3","volume":"179","author":"N Zinner","year":"2008","unstructured":"Zinner N, Scholfield D, Soma K, Darekar A, Symonds T, Mills I. Improvement in incontinence quality of life (i-qol) and patient global impression of change (pgic) measures in women with stress urinary incontinence (sui) following treatment with [s, s] - reboxetine (ssrbx). J Urol. 2008;179(4S):111\u2013111. https:\/\/doi.org\/10.1016\/S0022-5347(08)60321-3.","journal-title":"J Urol"},{"key":"1405_CR27","doi-asserted-by":"crossref","unstructured":"Colombage U, Soh S-E, Lin K-Y, White M, Vincent A, Fox J, Frawley H. Prevalence and impact of pelvic floor dysfunction in women with and without breast cancer: a cross-sectional study. (Under review) 2021.","DOI":"10.1016\/j.cont.2022.100494"},{"issue":"6","key":"1405_CR28","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s00192-019-04012-wFromNLM","volume":"31","author":"S Bernard","year":"2020","unstructured":"Bernard S, Boucher S, McLean L, Moffet H. Mobile technologies for the conservative self-management of urinary incontinence: a systematic scoping review. Int Urogynecol J. 2020;31(6):1163\u201374. https:\/\/doi.org\/10.1007\/s00192-019-04012-wFromNLM.","journal-title":"Int Urogynecol J"},{"issue":"8","key":"1405_CR29","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/nau.22657FromNLM","volume":"34","author":"E Nystr\u00f6m","year":"2015","unstructured":"Nystr\u00f6m E, Sj\u00f6str\u00f6m M, Stenlund H, Samuelsson E. ICIQ symptom and quality of life instruments measure clinically relevant improvements in women with stress urinary incontinence. Neurourol Urodyn. 2015;34(8):747\u201351. https:\/\/doi.org\/10.1002\/nau.22657FromNLM.","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"1405_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2478\/v10109-010-0052-5","volume":"18","author":"L Beutten-m\u00fcller","year":"2010","unstructured":"Beutten-m\u00fcller L, Cader S, Macena R, Araujo N, Nunes \u00c9, Dantas E. Muscle contraction of the pelvic floor and quality of life of women with stress urinary incontinence who underwent kinesitherapy. Fizjoterapia. 2010;18(1):35. https:\/\/doi.org\/10.2478\/v10109-010-0052-5.","journal-title":"Fizjoterapia"},{"key":"1405_CR31","doi-asserted-by":"publisher","DOI":"10.1177\/2055207619867223FromNLM","author":"C Benedict","year":"2019","unstructured":"Benedict C, Hahn AL, Diefenbach MA, Ford JS. Recruitment via social media: advantages and potential biases. Digit Health. 2019. https:\/\/doi.org\/10.1177\/2055207619867223FromNLM.","journal-title":"Digit Health"},{"issue":"12","key":"1405_CR32","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s00192-015-2749-y","volume":"26","author":"C Ferreira","year":"2015","unstructured":"Ferreira C, Dwyer P, Davidson M, Souza A, Ugarte J, Frawley H. Does pelvic floor muscle training improve female sexual function? A systematic review. Int Urogynecol J Pelvic Floor Dysfunct. 2015;26(12):1735\u201350. https:\/\/doi.org\/10.1007\/s00192-015-2749-y.","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"issue":"4","key":"1405_CR33","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s00192-020-04519-7","volume":"32","author":"I Ignjatovic","year":"2021","unstructured":"Ignjatovic I, Potic M, Basic D, Dinic L, Skakic A. Laparoscopic minimally invasive sacrocolpopexy or hysteropexy and transobturator tape combined with native tissue repair of the vaginal compartments in patients with advanced pelvic organ prolapse and incontinence. Int Urogynecol J. 2021;32(4):967\u201374. https:\/\/doi.org\/10.1007\/s00192-020-04519-7.","journal-title":"Int Urogynecol J"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-022-01405-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-022-01405-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-022-01405-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T14:13:39Z","timestamp":1672841619000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12282-022-01405-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,26]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["1405"],"URL":"https:\/\/doi.org\/10.1007\/s12282-022-01405-6","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,26]]},"assertion":[{"value":"8 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jennifer Kruger is the CEO of JUNOFEM, the company responsible for the development of the intra-vaginal pressure biofeedback device, femfit<sup>\u00ae<\/sup>, used in this study. This author was not involved in the recruitment and data collection process, and did not have any contact with study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}